Akero Therapeutics Funding: $65M Raised, Series A (2018)

Akero Therapeutics is based in South San Francisco, CA. It has raised $65M in total funding. Latest round: Series A.

Akero Therapeutics funding overview

Akero Therapeutics is based in South San Francisco, CA. Akero Therapeutics has raised $65M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in June 2018. The round record for Akero Therapeutics runs through 2018; nothing later has been disclosed. Investors on record include Apple Tree Partners, Atlas Venture, venBio Partners, Versant Ventures. 4 distinct backers are named across the disclosed rounds.

Akero Therapeutics at a glance

Total raised
$65M
Latest round
Series A
Latest round date
June 2018
Headquarters
South San Francisco, CA
Notable investors
Apple Tree Partners, Atlas Venture, venBio Partners, Versant Ventures

Frequently asked about Akero Therapeutics funding

How much has Akero Therapeutics raised?
Akero Therapeutics has raised $65M in total disclosed funding across the rounds on record.
Who has invested in Akero Therapeutics?
Apple Tree Partners, Atlas Venture, venBio Partners, Versant Ventures are named among the investors backing Akero Therapeutics.
What was the latest Akero Therapeutics funding round?
The most recent disclosed round is a Series A, announced in June 2018.
Where is Akero Therapeutics based?
Akero Therapeutics is based in South San Francisco, CA.
When did Akero Therapeutics last raise?
The last disclosed Akero Therapeutics round closed in June 2018 at Series A.

Every Akero Therapeutics figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in South San Francisco at a similar stage.

Companies related to Akero Therapeutics (31)

Browse related funding lists (7)

Company funding database · Investor directory · Founder database · Mega-rounds 2026